# The Role of Adjuvant Corneal Crosslinking in the Management of Infective Keratitis

> **NCT06967376** · EARLY_PHASE1 · COMPLETED · sponsor: **Research Institute of Ophthalmology, Egypt** · enrollment: 40 (actual)

## Conditions studied

- Infective Keratitis

## Interventions

- **PROCEDURE:** Corneal Collagen Cross-Linking Solutions
- **DRUG:** Topical Antimicrobial/Antifungal Medications

## Key facts

- **NCT ID:** NCT06967376
- **Lead sponsor:** Research Institute of Ophthalmology, Egypt
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-21
- **Primary completion:** 2021-11-11
- **Final completion:** 2022-02-03
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06967376

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06967376, "The Role of Adjuvant Corneal Crosslinking in the Management of Infective Keratitis". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06967376. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*